Literature DB >> 27599088

What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?

Ivan Gentile1, Alberto Enrico Maraolo1, Guglielmo Borgia1.   

Abstract

Entities:  

Keywords:  Ceftolozane/tazobactam; Enterobacteriaceae; Pseudomonas aeruginosa; carbapenem-sparing regimens; ceftazidime/avibactam; complicated intra-abdominal infections; complicated urinary tract infections; multidrug-resistance

Mesh：

Substances：

Year:  2016        PMID： 27599088     DOI： 10.1080/14787210.2016.1233060

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN： 1478-7210            Impact factor:   5.091


× No keyword cloud information.
  6 in total

Review 1.  Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection.

Authors:  Colleen S Curran; Thomas Bolig; Parizad Torabi-Parizi
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

2.  Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single-center experience.

Authors:  A R Buonomo; A E Maraolo; R Scotto; M Foggia; E Zappulo; P Congera; S Parente; I Gentile
Journal:  Infection       Date:  2020-01-24       Impact factor: 3.553

3.  Cyclic Boronates Inhibit All Classes of β-Lactamases.

Authors:  Samuel T Cahill; Ricky Cain; David Y Wang; Christopher T Lohans; David W Wareham; Henry P Oswin; Jabril Mohammed; James Spencer; Colin W G Fishwick; Michael A McDonough; Christopher J Schofield; Jürgen Brem
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

4.  New β-Lactam Antibiotics and Ceragenins - A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa.

Authors:  Paulina Paprocka; Bonita Durnaś; Angelika Mańkowska; Karol Skłodowski; Grzegorz Król; Magdalena Zakrzewska; Michał Czarnowski; Patrycja Kot; Kamila Fortunka; Stanisław Góźdź; Paul B Savage; Robert Bucki
Journal:  Infect Drug Resist       Date:  2021-12-25       Impact factor: 4.003

Review 5.  Ceftolozane/Tazobactam for Resistant Drugs Pseudomonas aeruginosa Respiratory Infections: A Systematic Literature Review of the Real-World Evidence.

Authors:  Luca Gregorio Giaccari; Maria Caterina Pace; Maria Beatrice Passavanti; Francesca Gargano; Caterina Aurilio; Pasquale Sansone
Journal:  Life (Basel)       Date:  2021-05-24

Review 6.  Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis.

Authors:  Marco Fiore; Alberto Enrico Maraolo; Ivan Gentile; Guglielmo Borgia; Sebastiano Leone; Pasquale Sansone; Maria Beatrice Passavanti; Caterina Aurilio; Maria Caterina Pace
Journal:  World J Hepatol       Date:  2017-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.